Charles Rhyee
Stock Analyst at TD Cowen
(0.84)
# 3,781
Out of 4,876 analysts
52
Total ratings
32.35%
Success rate
-13.28%
Average return
Main Sectors:
Stocks Rated by Charles Rhyee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICLR ICON Public Limited Company | Downgrades: Hold | $254 → $157 | $144.56 | +8.61% | 4 | Apr 14, 2025 | |
| MEDP Medpace Holdings | Downgrades: Hold | $370 → $328 | $310.69 | +5.57% | 4 | Apr 14, 2025 | |
| CAH Cardinal Health | Upgrades: Buy | $130 → $144 | $167.18 | -13.87% | 2 | Jan 8, 2025 | |
| CRL Charles River Laboratories International | Maintains: Hold | $203 → $227 | $150.01 | +51.32% | 5 | Nov 11, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $23 → $25 | $4.98 | +402.01% | 3 | Nov 11, 2024 | |
| TDOC Teladoc Health | Maintains: Hold | $9 → $8 | $8.41 | -4.88% | 6 | Oct 31, 2024 | |
| VEEV Veeva Systems | Maintains: Hold | $180 → $192 | $283.41 | -32.25% | 3 | Aug 29, 2024 | |
| GDRX GoodRx Holdings | Maintains: Buy | $14 → $16 | $4.90 | +226.53% | 7 | May 16, 2024 | |
| TALK Talkspace | Maintains: Outperform | $4 → $5 | $2.77 | +80.51% | 2 | May 3, 2023 | |
| AMWL American Well | Downgrades: Market Perform | $100 → $50 | $7.94 | +529.72% | 3 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $251 | $157.47 | +59.40% | 1 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $56 | $7.83 | +615.20% | 2 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 → $14 | $0.70 | +1,900.00% | 3 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $50 | $11.16 | +348.03% | 2 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $325 → $361 | $725.78 | -50.26% | 3 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $3,240 | $0.55 | +585,371.63% | 1 | Jul 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $35 | $21.58 | +62.19% | 1 | Feb 13, 2018 |
ICON Public Limited Company
Apr 14, 2025
Downgrades: Hold
Price Target: $254 → $157
Current: $144.56
Upside: +8.61%
Medpace Holdings
Apr 14, 2025
Downgrades: Hold
Price Target: $370 → $328
Current: $310.69
Upside: +5.57%
Cardinal Health
Jan 8, 2025
Upgrades: Buy
Price Target: $130 → $144
Current: $167.18
Upside: -13.87%
Charles River Laboratories International
Nov 11, 2024
Maintains: Hold
Price Target: $203 → $227
Current: $150.01
Upside: +51.32%
Fortrea Holdings
Nov 11, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $4.98
Upside: +402.01%
Teladoc Health
Oct 31, 2024
Maintains: Hold
Price Target: $9 → $8
Current: $8.41
Upside: -4.88%
Veeva Systems
Aug 29, 2024
Maintains: Hold
Price Target: $180 → $192
Current: $283.41
Upside: -32.25%
GoodRx Holdings
May 16, 2024
Maintains: Buy
Price Target: $14 → $16
Current: $4.90
Upside: +226.53%
Talkspace
May 3, 2023
Maintains: Outperform
Price Target: $4 → $5
Current: $2.77
Upside: +80.51%
American Well
Mar 23, 2023
Downgrades: Market Perform
Price Target: $100 → $50
Current: $7.94
Upside: +529.72%
Dec 6, 2022
Initiates: Outperform
Price Target: $251
Current: $157.47
Upside: +59.40%
Oct 20, 2022
Maintains: Outperform
Price Target: $70 → $56
Current: $7.83
Upside: +615.20%
Aug 16, 2022
Maintains: Outperform
Price Target: $18 → $14
Current: $0.70
Upside: +1,900.00%
Jun 21, 2022
Maintains: Outperform
Price Target: $48 → $50
Current: $11.16
Upside: +348.03%
Apr 18, 2022
Maintains: Outperform
Price Target: $325 → $361
Current: $725.78
Upside: -50.26%
Jul 16, 2020
Initiates: Outperform
Price Target: $3,240
Current: $0.55
Upside: +585,371.63%
Feb 13, 2018
Initiates: Market Perform
Price Target: $35
Current: $21.58
Upside: +62.19%